|
Index of reports
> Life Threatening Events (2)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Locoid (Hydrocortisone Topical) life threatening events. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Locoid side effects in male
Reported by a physician from Japan on 2012-04-02
Patient: male
Reactions: Acute Myocardial Infarction
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Bufferin
Administration route: Oral
Indication: Acute Coronary Syndrome
Start date: 2011-10-19
Carvedilol
Administration route: Oral
Indication: Tachycardia
Start date: 2011-12-19
Lipitor
Administration route: Oral
Indication: Hyperlipidaemia
Start date: 2011-10-20
Claritin
Administration route: Oral
Indication: Eczema
Start date: 2011-10-18
Magnesium Oxide
Dosage: as required
Administration route: Oral
Indication: Constipation
Start date: 2011-10-24
Placebo
Dosage: once daily
Administration route: Oral
Indication: Acute Coronary Syndrome
Start date: 2011-10-19
Rinderon-VG
Dosage: as rquired
Indication: Eczema
Locoid
Dosage: as required
Indication: Eczema
Azd6140
Dosage: two times a day
Administration route: Oral
Indication: Acute Coronary Syndrome
Start date: 2011-10-19
Sigmart
Administration route: Oral
Indication: Cardiovascular Event Prophylaxis
Start date: 2011-10-27
Famotidine
Administration route: Oral
Indication: Gastritis Prophylaxis
Start date: 2011-10-19
Hydrophilic
Dosage: as required
Indication: Eczema
Possible Locoid side effects in male
Reported by a physician from Japan on 2011-12-28
Patient: male
Reactions: Ventricular Fibrillation
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Plavix
Dosage: two times a day
Administration route: Oral
Indication: Acute Coronary Syndrome
Start date: 2011-10-19
Rinderon-VG
Dosage: as rquired
Indication: Eczema
Famotidine
Administration route: Oral
Indication: Gastritis Prophylaxis
Start date: 2011-10-19
Carvedilol
Administration route: Oral
Indication: Tachycardia
Start date: 2011-12-19
Locoid
Dosage: as required
Indication: Eczema
Claritin
Administration route: Oral
Indication: Eczema
Start date: 2011-10-18
Bufferin
Administration route: Oral
Indication: Acute Coronary Syndrome
Start date: 2011-10-19
Sigmart
Administration route: Oral
Indication: Cardiovascular Event Prophylaxis
Start date: 2011-10-27
Lipitor
Administration route: Oral
Indication: Hyperlipidaemia
Start date: 2011-10-20
Placebo
Dosage: once daily
Administration route: Oral
Indication: Acute Coronary Syndrome
Start date: 2011-10-19
Magnesium Oxide
Dosage: as required
Administration route: Oral
Indication: Constipation
Start date: 2011-10-24
Hydrophilic
Dosage: as required
Indication: Eczema
|
